Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (901-910 of 7,117) with videos related to

Pageof 712
Sort By:
Cancer Science|December 12, 2018
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, et al.
Cancer Science|January 15, 2019
Shortcuts to intestinal carcinogenesis by genetic engineering in organoidsYoshiaki Maru, Kunishige Onuma, Masako Ochiai, et al.
Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Cancer Science|November 3, 2019
Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinomaYouwei Zhang, He Du, Yang Li, et al.
Cancer Science|November 3, 2019
Immunological features of a lung cancer patient achieving an objective response with anti-programmed death-1 blockade therapyToshiko Kamata, Shigetoshi Yoshida, Mariko Takami, et al.
Cancer Science|December 1, 2019
Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapyJun He, Jun Cheng, Qingzhou Guan, et al.
Cancer Science|December 5, 2019
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumorsTakafumi Koyama, Toshio Shimizu, Satoru Iwasa, et al.
Cancer Science|November 29, 2019
Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrumMitsuko Furuya, Hisashi Hasumi, Masahiro Yao, et al.
Cancer Science|December 5, 2019
Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinomaYasunari Fukuda, Tadafumi Asaoka, Hidetoshi Eguchi, et al.
Cancer Science|February 15, 2020
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancerYueping Zhan, Yanyan Qiu, Haijing Wang, et al.
Pageof 712

Showing results (901-910 of 7,117) with videos related to

Sort By:
Pageof 712
Cancer Science|December 12, 2018
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, et al.
Cancer Science|January 15, 2019
Shortcuts to intestinal carcinogenesis by genetic engineering in organoidsYoshiaki Maru, Kunishige Onuma, Masako Ochiai, et al.
Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Cancer Science|November 3, 2019
Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinomaYouwei Zhang, He Du, Yang Li, et al.
Cancer Science|November 3, 2019
Immunological features of a lung cancer patient achieving an objective response with anti-programmed death-1 blockade therapyToshiko Kamata, Shigetoshi Yoshida, Mariko Takami, et al.
Cancer Science|December 1, 2019
Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapyJun He, Jun Cheng, Qingzhou Guan, et al.
Cancer Science|December 5, 2019
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumorsTakafumi Koyama, Toshio Shimizu, Satoru Iwasa, et al.
Cancer Science|November 29, 2019
Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrumMitsuko Furuya, Hisashi Hasumi, Masahiro Yao, et al.
Cancer Science|December 5, 2019
Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinomaYasunari Fukuda, Tadafumi Asaoka, Hidetoshi Eguchi, et al.
Cancer Science|February 15, 2020
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancerYueping Zhan, Yanyan Qiu, Haijing Wang, et al.
Pageof 712